Digoxin Tablet
Product Images NDC 0904-5921

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 0904-5921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C97d2c6b 8c11 4d67 B951 Cb748c1daac2 00

Label for Digoxin Tablets, USP 250 mcg (0.25 mg) oral tablets by Major Pharmaceuticals. The label indicates unit dose packaging with 100 tablets, prescription only. It includes directions for storage and handling, manufacturer and distributor information, and the National Drug Code (NDC) 0904-5922-61.*

FDA Label Image

C97d2c6b 8c11 4d67 B951 Cb748c1daac2 01

Label for Digoxin Tablets, USP 125 mcg (0.125 mg) oral tablets by Major Pharmaceuticals. The label indicates a unit dose package containing 100 scored tablets. It includes dosing and storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Structural Image (Digoxin Tablet 1)

Chemical structure of Digoxin shown as a detailed molecular diagram illustrating the steroid and sugar components of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.